Answer Questions for Patients Switching to a Biosimilar

August 2019

More questions will come up about biosimilars...now that BC will require patients to switch to biosimilars to save healthcare dollars.

Biosimilars are biologics that are highly SIMILAR to the original, or "reference," biologic...but cost up to 50% less.

For example, patients in BC may be switched from Lantus to Basaglar (insulin glargine)...Enbrel to Brenzys or Erelzi (etanercept)...or Remicade to Inflectra or Renflexis (infliximab).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Biosimilars Answer Questions for Patients Switching to a Biosimilar
Cannabinoids Explain the Effects of Recreational Cannabis on Diabetes
Photosensitivity Identify and Manage Med-Induced Photosensitivity
Pregnancy Weigh OTC Options for Treating GI Issues in Pregnancy
Diabetes Consider Cardiovascular Benefits When Recommending a GLP-1 Agonist
HIV & AIDS Know How to Manage Dyslipidemia in Patients Living With HIV
Lupus Be Familiar With Nuances for Managing Lupus
Opioids Don't Think of Tramadol as a "Safer" Opioid
Patient Safety Tell Patients to Avoid Unsafe Stem Cells
OTC Products Recommend Alternatives to Gentian Violet for Common Infections

Answer Questions for Patients Switching to a Biosimilar

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents